Table 1 Demographics and COVID-19 symptoms in migraine patients and controls

Age [(median (IQR)]

30 (15.5- 43)

36 (30- 42.75)

0.054

Sex [n (%)]

Male

41 (20.1%)

53 (26.0%)

0.158

1.395

0.877

2.219

Female

163 (79.9%)

151 (74.0%)

COVID-19 symptoms [n (%)]

Fever

130 (63.7%)

143 (70.1%)

0.171

0.749

0.495

1.134

Cough/dyspnea

136 (66.7%)

117 (57.4%)

0.053

1.487

0.995

2.223

Vomiting/diarrhea

73 (35.8%)

61 (29.9%)

0.206

1.306

0.863

1.977

Fatigue

164 (80.4%)

156 (76.5%)

0.336

1.262

0.786

2.025

Headache

153 (75%)

133 (65.2%)

0.031*

1.602

1.044

2.458

Ageusia/hypogeusia

97 (47.5%)

92 (45.1%)

0.62

1.104

0.748

1.629

Anosmia/hyposmia

119 (58.3%)

108 (52.9%)

0.273

1.244

0.842

1.84

others

19 (9.3%)

18 (8.8%)

0.863

1.061

0.54

2.086

COVID-19 severity ^a [n (%)]

Mild

177 (86.8%)

165 (80.9%)

0.124

Moderate

23 (11.3%)

28 (13.7%)

Severe

4 (2%)

11 (5.4%)

Full vaccination before COVID-19 infection

36 (17.6%)

39 (19.1%)

0.701

0.907

0.549

1.497